<- Go Home
Innovus Pharmaceuticals, Inc.
Innovus Pharmaceuticals, Inc. operates as an over-the-counter consumer goods and specialty pharmaceutical company in the United States and Canada. It engages in the development, licensing, and commercialization of non-prescription medicines, consumer care products, supplements, and medical devices to enhance men’s and women’s health and vitality. The company provides approximately 35 products with a focus on categories, such as sexual health, pain management, general muscle health, respiratory, sleep, and diabetic care. Its principal products include Vesele, UriVarx, FlutiCare, Apeaz, Diabasens, Prostagorx, and Sensum. The company markets and sells its products through commercial partners to physicians, urologists, gynecologists, therapists, and other healthcare providers; and directly to consumers through online channels, retailers, and wholesalers. Innovus Pharmaceuticals, Inc. was founded in 2008 and is headquartered in San Diego, California. Innovus Pharmaceuticals, Inc. was a former subsidiary of Aytu BioPharma, Inc.
Market Cap
$3.9M
Volume
7.0K
Cash and Equivalents
$955.0K
EBITDA
-$5.0M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$15.8M
Profit Margin
69.48%
52 Week High
$11.50
52 Week Low
$0.75
Dividend
N/A
Price / Book Value
-1.61
Price / Earnings
-0.38
Price / Tangible Book Value
-0.51
Enterprise Value
N/A
Enterprise Value / EBITDA
N/A
Operating Income
-$5.7M
Return on Equity
1431.50%
Return on Assets
-37.75
Cash and Short Term Investments
$955.0K
Debt
$4.1M
Equity
-$2.0M
Revenue
$22.7M
Unlevered FCF
-$687.5K
Sector
Pharmaceuticals
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium